Article · 24 Aug 2024
Conference abstractPublished 21 Oct 2013
Validation for the regulated industries
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Validation is a critical element in an organization?s quality management system to help ensure that delivered products and services are consistent, reliable, and in compliance with applicable international regulatory requirements and standards. While the ?process? of validation is typically viewed as a stand-alone activity, it is, in actuality, closely linked to risk management, quality management, design controls, and corporate strategy. To compound the issue, confusion abounds when the terms ?validation? and ?verification? are used - at times incorrectly. This presentation will focus on some of the validation basics and the regulatory requirements that need to be satisfied. The validation ?process? will be broken down into several buckets to help clarify the activities to be performed and the timing to do so. The concept of design space and its implications to validation will be explained. Also to be covered are the Validation Life Cycle, validation deliverables, and the types of validation that can be performed - including the opinions of regulatory agencies with respect to each of the methods. A template for a Validation Master Plan will also be provided to participants.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 12 Nov 2013
A risk based scientific approach to analytical method development and validation activities for regulated laboratories
Conference abstract · 12 Nov 2013
Risk-based validation of single-sign-on access control to GxP regulated systems
Conference abstract · 21 Oct 2013
A cost-effective and practical approach to risk-based computerized system validation (CSV) for pharmaceutical and medical devices regulated environments
Opinion · 4 May 2023
Process of Validation and Qualification in Phar maceutical Industry
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Les Schnoll”

